Literature DB >> 7544001

Interleukin 2 signaling involves the phosphorylation of Stat proteins.

D A Frank1, M J Robertson, A Bonni, J Ritz, M E Greenberg.   

Abstract

One of the most important cytokines involved in immune response regulation is interleukin 2 (IL-2), a potent activator of the proliferation and function of T lymphocytes and natural killer cells. The mechanisms by which the effects of IL-2 are propagated within cells are not understood. While the binding of IL-2 to its receptor was recently shown to lead to the activation of two kinases, Jak-1 and Jak-3, subsequent steps in the signaling pathway to the nucleus that lead to the activation of specific genes had not been characterized. Since many cytokines that activate Jak kinases also lead to the tyrosine phosphorylation and activation of members of the Stat family of transcription factors, the ability of IL-2 to trigger Stat phosphorylation was examined. Exposure of activated human T lymphocytes or of a natural killer cell line (NKL) to IL-2 leads to the phosphorylation of Stat1 alpha, Stat1 beta, and Stat3, as well as of two Stat-related proteins, p94 and p95. p94 and p95 share homology with Stat1 at the phosphorylation site and in the Src homology 2 (SH2) domain, but otherwise are immunologically distinct from Stat1. These Stat proteins were found to translocate to the nucleus and to bind to a specific DNA sequence. These findings suggest a mechanism by which IL-2 binding to its receptor may activate specific genes involved in immune cell function.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7544001      PMCID: PMC41229          DOI: 10.1073/pnas.92.17.7779

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  36 in total

1.  Selective in vitro growth of T lymphocytes from normal human bone marrows.

Authors:  D A Morgan; F W Ruscetti; R Gallo
Journal:  Science       Date:  1976-09-10       Impact factor: 47.728

2.  T-lymphocyte interleukin 2-dependent tyrosine protein kinase signal transduction involves the activation of p56lck.

Authors:  I D Horak; R E Gress; P J Lucas; E M Horak; T A Waldmann; J B Bolen
Journal:  Proc Natl Acad Sci U S A       Date:  1991-03-01       Impact factor: 11.205

3.  SH2 and SH3 domains: elements that control interactions of cytoplasmic signaling proteins.

Authors:  C A Koch; D Anderson; M F Moran; C Ellis; T Pawson
Journal:  Science       Date:  1991-05-03       Impact factor: 47.728

4.  Interleukin-2-triggered Raf-1 expression, phosphorylation, and associated kinase activity increase through G1 and S in CD3-stimulated primary human T cells.

Authors:  A Zmuidzinas; H J Mamon; T M Roberts; K A Smith
Journal:  Mol Cell Biol       Date:  1991-05       Impact factor: 4.272

5.  Interleukin-2 induction of T-cell G1 progression and c-myb expression.

Authors:  J B Stern; K A Smith
Journal:  Science       Date:  1986-07-11       Impact factor: 47.728

6.  Functional activation of Jak1 and Jak3 by selective association with IL-2 receptor subunits.

Authors:  T Miyazaki; A Kawahara; H Fujii; Y Nakagawa; Y Minami; Z J Liu; I Oishi; O Silvennoinen; B A Witthuhn; J N Ihle
Journal:  Science       Date:  1994-11-11       Impact factor: 47.728

7.  Recombinant interleukin 2 regulates levels of c-myc mRNA in a cloned murine T lymphocyte.

Authors:  J C Reed; D E Sabath; R G Hoover; M B Prystowsky
Journal:  Mol Cell Biol       Date:  1985-12       Impact factor: 4.272

8.  Overlapping elements in the guanylate-binding protein gene promoter mediate transcriptional induction by alpha and gamma interferons.

Authors:  D J Lew; T Decker; I Strehlow; J E Darnell
Journal:  Mol Cell Biol       Date:  1991-01       Impact factor: 4.272

9.  Interleukin 2 and diacylglycerol stimulate phosphorylation of 40 S ribosomal S6 protein. Correlation with increased protein synthesis and S6 kinase activation.

Authors:  S W Evans; W L Farrar
Journal:  J Biol Chem       Date:  1987-04-05       Impact factor: 5.157

10.  Interleukin 2 induces tyrosine phosphorylation and activation of p72-74 Raf-1 kinase in a T-cell line.

Authors:  B Turner; U Rapp; H App; M Greene; K Dobashi; J Reed
Journal:  Proc Natl Acad Sci U S A       Date:  1991-02-15       Impact factor: 11.205

View more
  31 in total

1.  IL-2 regulates the expression of the tumor suppressor IL-24 in melanoma cells.

Authors:  Emily Y Jen; Nancy J Poindexter; Elizabeth S Farnsworth; Elizabeth A Grimm
Journal:  Melanoma Res       Date:  2012-02       Impact factor: 3.599

2.  Identification of human STAT5-dependent gene regulatory elements based on interspecies homology.

Authors:  Erik A Nelson; Sarah R Walker; Wei Li; X Shirley Liu; David A Frank
Journal:  J Biol Chem       Date:  2006-07-13       Impact factor: 5.157

3.  CD25 expression and outcomes in older patients with acute myelogenous leukemia treated with plerixafor and decitabine.

Authors:  John N Allan; Gail J Roboz; Gulce Askin; Ellen Ritchie; Joseph Scandura; Paul Christos; Duane C Hassane; Monica L Guzman
Journal:  Leuk Lymphoma       Date:  2017-07-18

Review 4.  Interleukin-2 receptor downstream events in regulatory T cells: implications for the choice of immunosuppressive drug therapy.

Authors:  Robert Zeiser; Robert S Negrin
Journal:  Cell Cycle       Date:  2007-12-18       Impact factor: 4.534

5.  Human T-cell leukemia virus type 1 pX-I and pX-II open reading frames are dispensable for the immortalization of primary lymphocytes.

Authors:  M D Robek; F H Wong; L Ratner
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

Review 6.  Investigation of NK cell function and their modulation in different malignancies.

Authors:  Gordana Konjevic; Vladimir Jurisic; Viktor Jovic; Ana Vuletic; Katarina Mirjacic Martinovic; Sandra Radenkovic; Ivan Spuzic
Journal:  Immunol Res       Date:  2012-04       Impact factor: 2.829

7.  IL-2 regulates FOXP3 expression in human CD4+CD25+ regulatory T cells through a STAT-dependent mechanism and induces the expansion of these cells in vivo.

Authors:  Emmanuel Zorn; Erik A Nelson; Mehrdad Mohseni; Fabrice Porcheray; Haesook Kim; Despina Litsa; Roberto Bellucci; Elke Raderschall; Christine Canning; Robert J Soiffer; David A Frank; Jerome Ritz
Journal:  Blood       Date:  2006-04-27       Impact factor: 22.113

Review 8.  Recent advances in the understanding of interleukin-2 signal transduction.

Authors:  F Gesbert; M Delespine-Carmagnat; J Bertoglio
Journal:  J Clin Immunol       Date:  1998-09       Impact factor: 8.317

9.  STAT3-mediated up-regulation of BLIMP1 Is coordinated with BCL6 down-regulation to control human plasma cell differentiation.

Authors:  Sean A Diehl; Heike Schmidlin; Maho Nagasawa; Simon D van Haren; Mark J Kwakkenbos; Etsuko Yasuda; Tim Beaumont; Ferenc A Scheeren; Hergen Spits
Journal:  J Immunol       Date:  2008-04-01       Impact factor: 5.422

10.  Inhibition of STAT3 signaling leads to apoptosis of leukemic large granular lymphocytes and decreased Mcl-1 expression.

Authors:  P K Epling-Burnette; J H Liu; R Catlett-Falcone; J Turkson; M Oshiro; R Kothapalli; Y Li; J M Wang; H F Yang-Yen; J Karras; R Jove; T P Loughran
Journal:  J Clin Invest       Date:  2001-02       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.